Cornerstone Capital Management Holdings LLC. decreased its position in shares of Heska Corporation (NASDAQ:HSKA) by 42.3% in the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 47,111 shares of the medical research company’s stock after selling 34,600 shares during the quarter. Cornerstone Capital Management Holdings LLC. owned 0.65% of Heska Corporation worth $4,808,000 at the end of the most recent reporting period.
A number of other institutional investors and hedge funds have also recently bought and sold shares of HSKA. Bank of New York Mellon Corp lifted its position in Heska Corporation by 29.6% during the first quarter. Bank of New York Mellon Corp now owns 202,552 shares of the medical research company’s stock worth $21,264,000 after purchasing an additional 46,231 shares during the period. BNP Paribas Arbitrage SA lifted its position in Heska Corporation by 1,306.0% during the first quarter. BNP Paribas Arbitrage SA now owns 1,167 shares of the medical research company’s stock worth $123,000 after purchasing an additional 1,084 shares during the period. Texas Permanent School Fund bought a new stake in Heska Corporation during the first quarter worth about $272,000. Mason Street Advisors LLC bought a new stake in Heska Corporation during the first quarter worth about $144,000. Finally, Envestnet Asset Management Inc. bought a new stake in Heska Corporation during the first quarter worth about $166,000. 81.36% of the stock is owned by institutional investors and hedge funds.
HSKA has been the subject of several recent analyst reports. BidaskClub cut shares of Heska Corporation from a “buy” rating to a “hold” rating in a research report on Sunday, July 16th. B. Riley reaffirmed a “neutral” rating and set a $85.00 price objective on shares of Heska Corporation in a research report on Friday, July 28th. Aegis upped their price objective on shares of Heska Corporation from $114.50 to $129.50 and gave the stock a “buy” rating in a research report on Tuesday, August 1st. Benchmark Co. upped their price objective on shares of Heska Corporation from $106.00 to $120.00 and gave the stock a “buy” rating in a research report on Thursday, August 3rd. Finally, Zacks Investment Research raised shares of Heska Corporation from a “hold” rating to a “buy” rating and set a $109.00 price objective for the company in a research report on Friday, August 4th. Five analysts have rated the stock with a hold rating and three have given a buy rating to the stock. Heska Corporation currently has a consensus rating of “Hold” and a consensus price target of $106.83.
In other Heska Corporation news, EVP Nancy Wisnewski sold 825 shares of Heska Corporation stock in a transaction dated Thursday, August 31st. The stock was sold at an average price of $102.21, for a total transaction of $84,323.25. Following the completion of the transaction, the executive vice president now owns 38,114 shares of the company’s stock, valued at approximately $3,895,631.94. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, CFO John Mcmahon sold 2,608 shares of Heska Corporation stock in a transaction dated Wednesday, August 30th. The shares were sold at an average price of $101.17, for a total value of $263,851.36. Following the transaction, the chief financial officer now directly owns 193 shares of the company’s stock, valued at approximately $19,525.81. The disclosure for this sale can be found here. 14.70% of the stock is owned by insiders.
COPYRIGHT VIOLATION WARNING: This report was originally reported by Stock Observer and is the sole property of of Stock Observer. If you are viewing this report on another publication, it was illegally copied and reposted in violation of United States & international trademark & copyright laws. The legal version of this report can be viewed at https://www.thestockobserver.com/2017/10/13/heska-corporation-hska-position-trimmed-by-cornerstone-capital-management-holdings-llc.html.
Heska Corporation (NASDAQ:HSKA) last posted its earnings results on Thursday, August 3rd. The medical research company reported $0.44 earnings per share for the quarter, beating the Zacks’ consensus estimate of $0.37 by $0.07. The business had revenue of $34.30 million during the quarter, compared to analyst estimates of $33.35 million. Heska Corporation had a return on equity of 15.87% and a net margin of 10.70%. The company’s quarterly revenue was up 14.3% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $0.35 EPS.
Heska Corporation Company Profile
Heska Corporation sells veterinary diagnostic and specialty products. The Company operates through two segments: Core Companion Animal Health (CCA) and Other Vaccines, Pharmaceuticals and Products (OVP). The CCA segment includes, primarily for canine and feline use, blood testing instruments and supplies, digital imaging products, software and services, local and cloud-based data services, allergy testing and immunotherapy, and single use offerings, such as in-clinic diagnostic tests and heartworm preventive products.
Receive News & Ratings for Heska Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Heska Corporation and related companies with MarketBeat.com's FREE daily email newsletter.